StonvexLoading…
StonvexStonvexStonvexCore line items from DSS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $20.76M | $19.10M | $25.93M | $28.38M |
Operating Income | $-14.43M | $-42.60M | $-50.78M | $-29.98M |
Net Income | $-23.93M | $-46.90M | $-60.63M | $-59.84M |
EPS (Diluted) | Not available | $-6.63 | $-8.20 | $-6.84 |
Total Assets | $67.63M | $106.45M | $153.19M | $248.91M |
Total Liabilities | $58.91M | $73.74M | Not available | Not available |
Cash & Equivalents | $6.21M | $11.43M | $6.62M | $16.18M |
Free Cash Flow OCF − CapEx | Not available | $-8.89M | $-20.01M | $-28.82M |
Shares Outstanding | 9.09M | 8.09M | 7.07M | 6.95M |